195 related articles for article (PubMed ID: 24960465)
1. iTEP nanoparticle-delivered salinomycin displays an enhanced toxicity to cancer stem cells in orthotopic breast tumors.
Zhao P; Dong S; Bhattacharyya J; Chen M
Mol Pharm; 2014 Aug; 11(8):2703-12. PubMed ID: 24960465
[TBL] [Abstract][Full Text] [Related]
2. An iTEP-salinomycin nanoparticle that specifically and effectively inhibits metastases of 4T1 orthotopic breast tumors.
Zhao P; Xia G; Dong S; Jiang ZX; Chen M
Biomaterials; 2016 Jul; 93():1-9. PubMed ID: 27060212
[TBL] [Abstract][Full Text] [Related]
3. Polymer-lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells.
Li J; Xu W; Yuan X; Chen H; Song H; Wang B; Han J
Int J Nanomedicine; 2017; 12():6909-6921. PubMed ID: 29075110
[TBL] [Abstract][Full Text] [Related]
4. Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells.
Wang Q; Liu F; Wang L; Xie C; Wu P; Du S; Zhou S; Sun Z; Liu Q; Yu L; Liu B; Li R
Int J Nanomedicine; 2020; 15():1283-1295. PubMed ID: 32161458
[TBL] [Abstract][Full Text] [Related]
5. Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells.
Wang Q; Yen YT; Xie C; Liu F; Liu Q; Wei J; Yu L; Wang L; Meng F; Li R; Liu B
Drug Deliv; 2021 Dec; 28(1):510-519. PubMed ID: 33657950
[TBL] [Abstract][Full Text] [Related]
6. Codelivery of salinomycin and docetaxel using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles to target both gastric cancer cells and cancer stem cells.
Li L; Cui D; Ye L; Li Y; Zhu L; Yang L; Bai B; Nie Z; Gao J; Cao Y
Anticancer Drugs; 2017 Oct; 28(9):989-1001. PubMed ID: 28692437
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in drug delivery systems for targeting cancer stem cells.
Duan H; Liu Y; Gao Z; Huang W
Acta Pharm Sin B; 2021 Jan; 11(1):55-70. PubMed ID: 33532180
[TBL] [Abstract][Full Text] [Related]
8. Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells.
Zeng YB; Yu ZC; He YN; Zhang T; Du LB; Dong YM; Chen HW; Zhang YY; Wang WQ
Acta Pharmacol Sin; 2018 Feb; 39(2):261-274. PubMed ID: 29388568
[TBL] [Abstract][Full Text] [Related]
9. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
10. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
[TBL] [Abstract][Full Text] [Related]
11. Combination of drug-conjugated SWCNT nanocarriers for efficient therapy of cancer stem cells in a breast cancer animal model.
Al Faraj A; Shaik AS; Ratemi E; Halwani R
J Control Release; 2016 Mar; 225():240-51. PubMed ID: 26827662
[TBL] [Abstract][Full Text] [Related]
12. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
Yang X; Shi X; Ji J; Zhai G
Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
[TBL] [Abstract][Full Text] [Related]
13. Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells.
Chen F; Zeng Y; Qi X; Chen Y; Ge Z; Jiang Z; Zhang X; Dong Y; Chen H; Yu Z
Nanomedicine; 2018 Oct; 14(7):2115-2127. PubMed ID: 29898423
[TBL] [Abstract][Full Text] [Related]
14. iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells.
Mao X; Liu J; Gong Z; Zhang H; Lu Y; Zou H; Yu Y; Chen Y; Sun Z; Li W; Li B; Gao J; Zhong Y
Nanomedicine (Lond); 2015; 10(17):2677-95. PubMed ID: 26355733
[TBL] [Abstract][Full Text] [Related]
15. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z
Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270
[TBL] [Abstract][Full Text] [Related]
16. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
[TBL] [Abstract][Full Text] [Related]
17. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment.
Kim YJ; Liu Y; Li S; Rohrs J; Zhang R; Zhang X; Wang P
Mol Pharm; 2015 Aug; 12(8):2811-22. PubMed ID: 26098197
[TBL] [Abstract][Full Text] [Related]
18. Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue.
Gote V; Nookala AR; Bolla PK; Pal D
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925129
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs.
Huang X; Borgström B; Kempengren S; Persson L; Hegardt C; Strand D; Oredsson S
BMC Cancer; 2016 Feb; 16():145. PubMed ID: 26906175
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E-based redox-sensitive salinomycin prodrug-nanosystem with paclitaxel loaded for cancer targeted and combined chemotherapy.
Liang DS; Liu J; Peng TX; Peng H; Guo F; Zhong HJ
Colloids Surf B Biointerfaces; 2018 Dec; 172():506-516. PubMed ID: 30212688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
